BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 14, 2024; 30(42): 4583-4586
Published online Nov 14, 2024. doi: 10.3748/wjg.v30.i42.4583
Endoscopic polidocanol foam sclerobanding for treatment of internal hemorrhoids: A novel outpatient procedure
An-Na Mou, Yu-Ting Wang
An-Na Mou, Yu-Ting Wang, Department of Radiology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan Province, China
Author contributions: Mou AN wrote the manuscript; Wang YT revised and approved the final version.
Conflict-of-interest statement: We have nothing to disclose for this article.
Corresponding author: Yu-Ting Wang, PhD, Professor, Department of Radiology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, No. 32 Section 2, 1st Ring Road (West), Chengdu 610072, Sichuan Province, China. wangyuting_330@163.com
Received: July 23, 2024
Revised: September 14, 2024
Accepted: October 14, 2024
Published online: November 14, 2024
Processing time: 99 Days and 19.4 Hours
Core Tip

Core Tip: The clinical manifestations, pathogenesis, classification, and treatment in patients with internal hemorrhoids are briefly summarized. Endoscopic rubber band ligation (RBL) and injection sclerotherapy are widely used and recommended as a first-line outpatient procedure for hemorrhoids. In the prospective and multicenter study performed by Qu et al, endoscopic polidocanol foam sclerobanding, combining endoscopic polidocanol foam sclerotherapy with RBL, is evaluated in a clinical trial as a new procedure. It is a unique method to treat grade II and grade III internal hemorrhoids by reducing prolapse recurrence, reducing 24-h post-procedural pain, and improving long-term efficacy compared with endoscopic RBL.